Literature DB >> 7575479

The secreted form of the Alzheimer's beta-amyloid precursor protein stimulates a membrane-associated guanylate cyclase.

S W Barger1, M P Mattson.   

Abstract

We previously demonstrated that secreted forms of the Alzheimer's beta-amyloid precursor protein (sAPP) elevate cyclic GMP (cGMP) in primary neuronal cultures and that this effect is responsible for the modulation of neuronal calcium homoeostasis by sAPP. We have investigated further the mechanism by which sAPP elevates cGMP. Inhibition of the formation of nitric oxide or carbon monoxide did not affect the ability of sAPP to lower rapidly intraneuronal calcium levels or elevate cGMP, suggesting that sAPP does not activate a soluble (cytosolic) guanylate cyclase. A dose-dependent stimulation of cGMP formation by sAPP was observed in brain membrane preparations. The stimulation was also dependent on the presence of ATP. These data suggest that sAPP activates a membrane-associated guanylate cyclase, perhaps similar to those present in the receptors for the natriuretic peptides and sperm motility factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575479      PMCID: PMC1136117          DOI: 10.1042/bj3110045

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

Authors:  E H Koo; S S Sisodia; D R Archer; L J Martin; A Weidemann; K Beyreuther; P Fischer; C L Masters; D L Price
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons.

Authors:  M P Mattson; B Rychlik; C Chu; S Christakos
Journal:  Neuron       Date:  1991-01       Impact factor: 17.173

Review 3.  The regulation and modulation of pH in the nervous system.

Authors:  M Chesler
Journal:  Prog Neurobiol       Date:  1990       Impact factor: 11.685

4.  Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension.

Authors:  L W Jin; H Ninomiya; J M Roch; D Schubert; E Masliah; D A Otero; T Saitoh
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

Review 5.  Guanylyl cyclase receptors.

Authors:  D L Garbers; D G Lowe
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

6.  Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts.

Authors:  T Saitoh; M Sundsmo; J M Roch; N Kimura; G Cole; D Schubert; T Oltersdorf; D B Schenk
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

7.  Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene.

Authors:  L Luo; T Tully; K White
Journal:  Neuron       Date:  1992-10       Impact factor: 17.173

8.  Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of beta-amyloid precursor.

Authors:  S W Barger; R R Fiscus; P Ruth; F Hofmann; M P Mattson
Journal:  J Neurochem       Date:  1995-05       Impact factor: 5.372

9.  Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.

Authors:  B Brüne; V Ullrich
Journal:  Mol Pharmacol       Date:  1987-10       Impact factor: 4.436

10.  Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.

Authors:  R M Nitsch; B E Slack; R J Wurtman; J H Growdon
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

View more
  11 in total

Review 1.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

Review 2.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

3.  Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype.

Authors:  Orwa Aboud; Robert E Mrak; Frederick A Boop; W Sue T Griffin
Journal:  Acta Neuropathol Commun       Date:  2013-07-29       Impact factor: 7.801

Review 4.  Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.

Authors:  Ahsan Habib; Darrell Sawmiller; Jun Tan
Journal:  J Neurosci Res       Date:  2016-08-17       Impact factor: 4.164

Review 5.  Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases.

Authors:  J I Kourie
Journal:  Cell Mol Neurobiol       Date:  2001-06       Impact factor: 5.046

Review 6.  Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.

Authors:  Sic L Chan; Katsutoshi Furukawa; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 7.  Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease.

Authors:  Simonetta Camandola; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-10-13

Review 8.  The dysregulation of intracellular calcium in Alzheimer disease.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2010-01-18       Impact factor: 6.817

9.  Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers.

Authors:  Matthias Gralle; Michelle Gralle Botelho; Fred S Wouters
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

10.  The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines.

Authors:  David A Hicks; Natalia Z Makova; Mallory Gough; Edward T Parkin; Natalia N Nalivaeva; Anthony J Turner
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.